Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06400264
Status:
WITHDRAWN
Last Update Posted:
2024-05-06
First Post:
2024-05-03
Brief Title:
Testing Nivolumab and BMS-986016 Relatlimab as Potentially Targeting Treatment in Cancers That Are LAG-3 and Have Mismatch Repair Deficiency MATCH - Subprotocol Z1M
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Refractory Multiple Myeloma |
| Advanced Lymphoma |
| Advanced Malignant Solid Neoplasm |
| Refractory Lymphoma |
| Refractory Malignant Solid Neoplasm |
Keywords: